Ethics and Integrity in Psychedelic Trials

This chapter examines serious misconduct allegations in a clinical trial conducted by Lycos, focusing on a sexual assault incident and the company's regulatory responses. It also addresses the implications of recent paper retractions and continued challenges in the psychedelics research field while highlighting the potential of psychedelics in treating mental illness.